PROLONGED GREATER-THAN 1 WEEK) SEDATION WITH MIDAZOLAM IN ICU PATIENTS - EFFICACY, SAFETY AND PHARMACOKINETICS

被引:0
|
作者
HEYTENS, L [1 ]
BOSSAERT, L [1 ]
机构
[1] UNIV HOSP ANTWERP,DEPT INTENS CARE,ANTWERP,BELGIUM
关键词
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:93 / 93
页数:1
相关论文
共 50 条
  • [41] THERAPEUTIC AND METABOLIC EFFECTS OF HIGH (GREATER-THAN 1 G M2) SYSTEMIC CUMULATIVE DOSES OF CIS-PLATINUM IN PATIENTS WITH OVARIAN-CARCINOMA
    PLAXE, SC
    DOTTINO, PR
    COHEN, CJ
    GYNECOLOGIC ONCOLOGY, 1990, 37 (02) : 250 - 253
  • [42] Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma
    Furuse, Junji
    Okusaka, Takuji
    Kaneko, Shuichi
    Kudo, Masatoshi
    Nakachi, Kohei
    Ueno, Hideki
    Yamashita, Tatsuya
    Ueshima, Kazuomi
    CANCER SCIENCE, 2010, 101 (12) : 2606 - 2611
  • [43] A Phase 1/2 Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of NI-03 in Patients With Chronic Pancreatitis
    Hart, P. A.
    Nuttall, J.
    PANCREAS, 2017, 46 (10) : 1405 - 1405
  • [44] CAN DIFFERENCES BE OBSERVED IN THE SAFETY AND EFFICACY OF ACARBOSE BETWEEN ELDERLY (GREATER-THAN-OR-EQUAL-TO-65 YEARS) COMPARED TO YOUNGER NIDDM PATIENTS
    GELLERT, E
    CAGATAY, M
    SPENGLER, M
    DIABETES, 1995, 44 : A215 - A215
  • [45] Pharmacokinetics, Safety, and Efficacy of FOLFIRI Plus Bevacizumab in Japanese Colorectal Cancer Patients With UGT1A1 Gene Polymorphisms
    Suenaga, Mitsukuni
    Fuse, Nozomu
    Yamaguchi, Tatsuro
    Yamanaka, Yasuhiro
    Motomura, Shigeki
    Matsumoto, Hiroshi
    Hamamoto, Yasuo
    Mizunuma, Nobuyuki
    Doi, Toshihiko
    Hatake, Kiyohiko
    Iwasaki, Junko
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 495 - 502
  • [46] Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma
    Igarashi, Ryoma
    Inoue, Takamitsu
    Fujiyama, Nobuhiro
    Tsuchiya, Norihiko
    Numakura, Kazuyuki
    Kagaya, Hideaki
    Saito, Mitsuru
    Narita, Shintaro
    Satoh, Shigeru
    Niioka, Takenori
    Miura, Masatomo
    Habuchi, Tomonori
    MEDICAL ONCOLOGY, 2018, 35 (04)
  • [47] Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma
    Ryoma Igarashi
    Takamitsu Inoue
    Nobuhiro Fujiyama
    Norihiko Tsuchiya
    Kazuyuki Numakura
    Hideaki Kagaya
    Mitsuru Saito
    Shintaro Narita
    Shigeru Satoh
    Takenori Niioka
    Masatomo Miura
    Tomonori Habuchi
    Medical Oncology, 2018, 35
  • [48] EFFICACY AND SAFETY OF IXEKIZUMAB AT WEEK 52 IN BIOLOGIC NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (SPIRIT-P1)
    Lespessailles, Eric
    Kirkham, Bruce
    Nebro, Antonio Fernandez
    Blanco, Ricardo
    Strehblow, Christoph
    Inciarte-Mundo, Jose
    Porsdal, Vibeke
    Garcia, Miriam
    Kurzawa, Monika
    Sapin, Christophe
    Geusens, Piet
    Goupille, Philippe
    Tahir, Hasan
    RHEUMATOLOGY, 2018, 57
  • [49] EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS
    Combe, B.
    Kivitz, A.
    Tanaka, Y.
    Van der Heijde, D.
    Simon-Campos, J. A.
    Baraf, H. S. B.
    Kumar, U.
    Matzkies, F.
    Bartok, B.
    Ye, L.
    Guo, Y.
    Tasset, C.
    Sundy, J.
    Jahreis, A.
    Mozaffarian, N.
    Landewe, R. B. M.
    Bae, S. C.
    Keystone, E.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 316 - 317
  • [50] SAFETY AND EFFICACY OF 1060nm NON-INVASIVE DIODE LASER FOR FAT REDUCTION IN PATIENTS WITH BODY MASS INDEX GREATER THAN 30
    Ferzli, Georgina M.
    Jeon, Hana
    Geronemus, Roy G.
    LASERS IN SURGERY AND MEDICINE, 2018, 50 : S51 - S52